Status:
COMPLETED
The EC90 of Remifentanil Blunting Hemodynamic Changes to Head Fixation
Lead Sponsor:
Seoul National University Hospital
Conditions:
Brain Tumor
AVM
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
The purpose of this study is to estimate the EC90 of remifentanil blunting hemodynamic changes to head fixation in the patients undergoing neurosurgery.
Eligibility Criteria
Inclusion
- patients undergoing neurosurgery that require head fixation with mayfield head holder
- patients who agree to our study
Exclusion
- patients who don't agree to our study
- BMI\<16.0 or BMI\>30
- cardiovascular disease, pulmonary disease, renal disease
- alcoholic abuser or drug abuser
- patients who takes any drug having an influence on cardiovascular system or sympathetic nervous system
- any use of local anesthetics or drugs which have an influence on cardiovascular system from beginning of induction to peri-fixation period
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01489137
Start Date
November 1 2011
Last Update
August 17 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, Seoul, South Korea, 110-744